Transcripts
Karyopharm Therapeutics (KPTI) earnings call transcripts
Earnings call transcripts for Karyopharm Therapeutics Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the quarter around an August myelofibrosis filing, while acknowledging financing needs and narrowing investment after endometrial cancer results.
Aug 13, 2026Mildly positive0.25